Slide background
Slide background

EudraBook Compendium of EU pharmaceutical law

ID 6831 | | Visite: 8876 | MedicinalPermalink:


EudraBook Compendium of EU pharmaceutical law

2015 marks the 50th anniversary of pharmaceutical legislation in the EU, which began with Directive 65/65 in 1965 in the wake of the Thalidomide disaster.

The EU legal framework for medicinal products for human use guarantees high standards of quality and safety of medicinal products and intends to promote the functioning of the internal market, with measures which encourage innovation and competiveness in Europe. It is based on the principle that medicinal products may be placed on the market only following a marketing authorisation granted by the competent authorities.

A large body of legislation has developed around this principle, with the progressive harmonisation of requirements for the granting of marketing authorisations since the 1960s, implemented across the whole European Economic Area.

Nowadays, medicinal products may be either authorised centrally by the European Commission or nationally by Member States’ competent authorities. The European Medicines Agency, established in 1995, underpins the centralised authorisation procedure and supports coordination between national competent authorities. The Agency is the hub of a European medicines network comprising over 40 national regulatory authorities guaranteeing a constant exchange and flow of information regarding the scientific assessment of medicinal products in the EU.

The EU legal framework is definitely not an area in which the law stands still. Quite the contrary, its history is marked by a constant ambition to improve its functioning or tackling shortcomings in order to guarantee the right balance between early access of patients to new medicines and high standards of quality and safety. Moreover, over the past 50 years science has developed. New technologies and further knowledge about diseases led to the introduction of new concepts or re-shaping of existing medical therapies that were subsequently mirrored in legislation.

The pharmaceutical sector is characterised by an abundance of guidelines intended to help and support the key players in the application of the EU legal framework. Still, the guidance documents would be nothing without the basic legislation on which they build.

To understand the EU legal framework for medicinal products it is important to know the applicable provisions of the legislation itself. This E-Book is intended to support readers in this regard by putting together the most recent versions of the key legal instruments on medicinal products for human use. It provides a useful overview for stakeholders, especially the pharmaceutical industry, regulatory authorities, legal practitioners, but also interested citizens, patients and healthcare professionals.

This E-Book reflects the law as it stands on 1 January 2015

Eudralex Ebook Version 1.3 06/05/2015

Scarica questo file (EudraBook Compendium of EU pharmaceutical law 2015.pdf)EudraBook Compendium of EU pharmaceutical law 2015
EN1558 kB807

Tags: Medicinal

Ultimi archiviati Chemicals

Mar 27, 2023 14

Decreto 20 marzo 2023

Decreto 20 marzo 2023 ID 19326 | 27.03.2023 Frequenza dei controlli fisici sulle partite di prodotti biologici e in conversione prima della loro immissione in libera pratica determinata in base alla valutazione della probabilita' di non conformita' alle disposizioni del regolamento (UE) 2018/848… Leggi tutto
Regolamento di esecuzione  UE  2023 680
Mar 24, 2023 49

Regolamento di esecuzione (UE) 2023/680

Regolamento di esecuzione (UE) 2023/680 / Approvazione Cloruro di alchil (C12-16) dimetilbenzilammonio Biocidi tipo prodotto 1 ID 19301 | 24.03.2023 Regolamento di esecuzione (UE) 2023/680 della Commissione del 23 marzo 2023 che approva il cloruro di alchil (C12-16) dimetilbenzilammonio (ADBAC/BKC… Leggi tutto
Regulatory strategy for flame retardants
Mar 15, 2023 84

Regulatory strategy for flame retardants

Regulatory strategy for flame retardants ID 19212 | ECHA 15.03.2023 Aromatic brominated flame retardants, such as polybrominated diphenyl ethers, are generally persistent in the environment. Many, like decabromodiphenylether, are also known or suspected of being toxic and accumulating in people and… Leggi tutto
REACH Authorisation List
Mar 09, 2023 52

REACH Authorisation Decisions List | Last update 09.03.2023

REACH Authorisation Decisions List / Last update: 09.03.2023 REACH Authorisation Decisions List of authorisation decisions adopted on the basis of Article 64 of Regulation (EC) No 1907/2006 (REACH). The list also includes reference to related documentation concerning all applications for… Leggi tutto
Guidance for monomers and polymers
Mar 08, 2023 93

Guidance for monomers and polymers

Guidance for monomers and polymers | ECHA Version 3.0 - February 2023 ID 19176 | 08.03.2023 / In allegato Linee guida ECHA Version 3.0 - February 2023 Polymers are the material of choice in a vast range of applications such as packaging, building and construction, transportation, electrical and… Leggi tutto
Regolamento UE 2023 465
Mar 06, 2023 253

Regolamento (UE) 2023/465

Regolamento (UE) 2023/465 / Tenori massimi di arsenico in alcuni alimenti ID 19148 | 06.03.2023 Regolamento (UE) 2023/465 della Commissione del 3 marzo 2023 recante modifica del regolamento (CE) n. 1881/2006 per quanto riguarda i tenori massimi di arsenico in alcuni alimenti GU L 68/51 del 6.3.2023… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Ott 24, 2022 77801

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto